Rapid Micro Biosystems Stock Performance
| RPID Stock | USD 0.86 0.08 8.51% |
The company holds a Beta of -0.12, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Rapid Micro are expected to decrease at a much lower rate. During the bear market, Rapid Micro is likely to outperform the market. Rapid Micro Biosystems right now holds a risk of 2.64%. Please check Rapid Micro Biosystems maximum drawdown and the relationship between the semi variance and day typical price , to decide if Rapid Micro Biosystems will be following its historical price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Rapid Micro Biosystems has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound forward indicators, Rapid Micro is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Last Split Factor 1:30 | Last Split Date 2010-10-29 |
1 | Acquisition by Robert Spignesi of 113000 shares of Rapid Micro subject to Rule 16b-3 | 02/08/2024 |
2 | Payment of 9365 shares by Robert Spignesi of Rapid Micro subject to Rule 16b-3 | 02/14/2024 |
3 | Rapid Micro Biosystems to Participate in Upcoming Investor Conferences - Yahoo Finance | 02/27/2024 |
4 | Rapid Micro Biosystems GAAP EPS of -0.26 beats by 0.04, revenue of 6.34M beats by 0.19M | 03/01/2024 |
5 | Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635 | 03/06/2024 |
6 | Disposition of 10323 shares by Robert Spignesi of Rapid Micro at 0.981 subject to Rule 16b-3 | 03/11/2024 |
7 | Rapid Micro Biosystems to Participate in the Virtual KeyBanc Life Sciences MedTech Investor Forum | 03/12/2024 |
8 | Rapid Micro Biosystems to Exhibit at the 2024 PDA Annual Meeting from March 25 - 27, 2024 | 03/19/2024 |
9 | Acquisition by Lowenstein Inese of 25000 shares of Rapid Micro at 0.8705 subject to Rule 16b-3 | 04/02/2024 |
10 | Acquisition by Chene David of 11125 shares of Rapid Micro at 3.9426 subject to Rule 16b-3 | 04/05/2024 |
| Begin Period Cash Flow | 27.1 M |
Rapid |
Rapid Micro Relative Risk vs. Return Landscape
If you would invest 97.00 in Rapid Micro Biosystems on January 19, 2024 and sell it today you would lose (0.75) from holding Rapid Micro Biosystems or give up 0.77% of portfolio value over 90 days. Rapid Micro Biosystems is currently generating 0.0221% in daily expected returns and assumes 2.6427% risk (volatility on return distribution) over the 90 days horizon. In different words, 23% of stocks are less volatile than Rapid, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Rapid Micro Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Rapid Micro's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Rapid Micro Biosystems, and traders can use it to determine the average amount a Rapid Micro's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0084
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | RPID |
Estimated Market Risk
| 2.64 actual daily | 23 77% of assets are more volatile |
Expected Return
| 0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Rapid Micro is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Rapid Micro by adding Rapid Micro to a well-diversified portfolio.
Rapid Micro Fundamentals Growth
Rapid Stock prices reflect investors' perceptions of the future prospects and financial health of Rapid Micro, and Rapid Micro fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Rapid Stock performance.
| Return On Equity | -0.37 | ||||
| Return On Asset | -0.21 | ||||
| Profit Margin | (2.33) % | ||||
| Operating Margin | (1.92) % | ||||
| Current Valuation | (45.63 M) | ||||
| Shares Outstanding | 37.48 M | ||||
| Price To Book | 0.34 X | ||||
| Price To Sales | 1.80 X | ||||
| Revenue | 22.52 M | ||||
| Gross Profit | (8.54 M) | ||||
| EBITDA | (53.46 M) | ||||
| Net Income | (52.47 M) | ||||
| Cash And Equivalents | 145.1 M | ||||
| Cash Per Share | 3.46 X | ||||
| Total Debt | 7.35 M | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 13.45 X | ||||
| Book Value Per Share | 2.78 X | ||||
| Cash Flow From Operations | (45.08 M) | ||||
| Earnings Per Share | (1.22) X | ||||
| Market Capitalization | 40.02 M | ||||
| Total Asset | 143.45 M | ||||
| Retained Earnings | (428.38 M) | ||||
| Working Capital | 101.43 M | ||||
| Current Asset | 217 K | ||||
| Current Liabilities | 6.84 M | ||||
About Rapid Micro Performance
To evaluate Rapid Micro Biosystems Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Rapid Micro generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Rapid Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Rapid Micro Biosystems market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Rapid's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 260.17 | 161.11 | |
| Return On Tangible Assets | (0.37) | (0.38) | |
| Return On Capital Employed | (0.45) | (0.48) | |
| Return On Assets | (0.37) | (0.38) | |
| Return On Equity | (0.44) | (0.42) |
Things to note about Rapid Micro Biosystems performance evaluation
Checking the ongoing alerts about Rapid Micro for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Rapid Micro Biosystems help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Rapid Micro has some characteristics of a very speculative penny stock | |
| Rapid Micro has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 22.52 M. Net Loss for the year was (52.47 M) with loss before overhead, payroll, taxes, and interest of (8.54 M). | |
| Rapid Micro Biosystems currently holds about 145.1 M in cash with (45.08 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.46, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Rapid Micro has a poor financial position based on the latest SEC disclosures | |
| Roughly 65.0% of the company shares are owned by institutional investors |
- Analyzing Rapid Micro's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Rapid Micro's stock is overvalued or undervalued compared to its peers.
- Examining Rapid Micro's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Rapid Micro's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Rapid Micro's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Rapid Micro's stock. These opinions can provide insight into Rapid Micro's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rapid Micro Biosystems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Rapid Stock analysis
When running Rapid Micro's price analysis, check to measure Rapid Micro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rapid Micro is operating at the current time. Most of Rapid Micro's value examination focuses on studying past and present price action to predict the probability of Rapid Micro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rapid Micro's price. Additionally, you may evaluate how the addition of Rapid Micro to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |
Is Rapid Micro's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rapid Micro. If investors know Rapid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rapid Micro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.22) | Revenue Per Share 0.523 | Quarterly Revenue Growth 0.449 | Return On Assets (0.21) | Return On Equity (0.37) |
The market value of Rapid Micro Biosystems is measured differently than its book value, which is the value of Rapid that is recorded on the company's balance sheet. Investors also form their own opinion of Rapid Micro's value that differs from its market value or its book value, called intrinsic value, which is Rapid Micro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rapid Micro's market value can be influenced by many factors that don't directly affect Rapid Micro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rapid Micro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rapid Micro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rapid Micro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.